Press release
PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files
The analysis information such as restriction analysis, ORF search and component fragment information is presented under separate tabs: features under the Feature tab, enzyme information under the Enzyme tab, ORF information under the ORF tab and component fragment information under the Note tab. This enables the data to be properly organized and in a format so that it is easily accessible.
“With this release, we are offering a cost effective but a powerful tool to all users who have their cloning research based on Vector NTI®.” said Kay Brown, V.P. Business Development and Marketing.
For details, please visit: http://www.premierbiosoft.com/plasmid_maps/VectorNTI.html
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
Founded in 1994, is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. Our goal is to study the most recent innovations in molecular biology and translate them into software products that aid the biologist.
PREMIER Biosoft International
3786 Corina Way
Palo Alto CA 94303-4504
USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files here
News-ID: 83370 • Views: …
More Releases for Vector
Growing Prevalence Of Vector-Borne Diseases Fuels Vector Control Market: Pivotal …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Vector Control Market Size Growth Forecast: What to Expect by 2025?
The market size of vector control has been experiencing robust growth in the past years, and it's predicted to increase from $20.53 billion in 2024 to $22.01 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. Factors such as urbanization…
Global Viral Vector Manufacturing Market Size by Application, Type, and Geograph …
USA, New Jersey- According to Market Research Intellect, the global Viral Vector Manufacturing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The viral vector manufacturing market is witnessing accelerated growth due to the rising demand for gene therapies and vaccines. These vectors are essential tools…
Prominent Viral Vector Manufacturing Market Trend for 2025: Product Innovation I …
How Are the key drivers contributing to the expansion of the viral vector manufacturing market?
The escalation in the occurrence of both cancer and contagious diseases is anticipated to spur the expansion of the viral vector manufacturing market in the future. An infectious disease is a condition caused by a virus or its harmful byproduct which spreads to a susceptible organism through contact with an infected individual, creature, or object. Cancer…
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size?
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow…
Viral Vector Manufacturing Market Report 2024 - Viral Vector Manufacturing Marke …
"The Business Research Company recently released a comprehensive report on the Global Viral Vector Manufacturing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Adeno-Associated Virus Vector Manufacturing Market - Building Better Therapies: …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Adeno-Associated Virus Vector Manufacturing Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Adeno-Associated Virus Vector Manufacturing provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and…
